|
D.A. Napalkov, A.A. Sokolova, A.V. Zhilenko
PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE
|
№13 / 2013
|
|
S.G. Kanorsky
PREVENTION OF THROMBOEMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION
|
№10 / 2013
|
|
I.V.Zotova, D.A.Zateyshchikov
XA FACTOR INHIBITOR RIVAROXABAN IN ATRIAL FIBRILLATION
|
№9 / 2013
|
|
T. V. Pavlova, E.Yu.Bulanova, D. V. Duplyakov
Amiodarone And Thyroid Dysfunction
|
№5 / 2013
|
|
S.V. Moiseyev
N-3 Polyunsaturated Fatty Acids In The Pharmacotherapy Of Atrial Fibrillation
|
№9 / 2012
|
|
D.A. Zateyshcikov, I.V. Zotova
Dabigatran: Prospects For Clinical Application
|
№15 / 2011
|
|
V.Ye. Volkov
Atrial Fibrillation Associated With Arterial Hypertension
|
№14 / 2011
|
|
V.Ye. Volkov, Yu.V. Dotsenko, I.Ye. Kiryushina
Modern Forms Of Drug Treatment Of Paroxysmal Atrial Fibrillation And Atrial Flutter
|
№8 / 2011
|
|
Sbrodova L. V., Volkov V.Y., Pshenitsin A. I., Kostoeva A. U., Mazur N. A. С. 7681
Dynamics Of Heart Rate Variability Under Pressure Of Therapy With Sotalol And Verapamil In Hypertensive Patients With Atrial Fibrillation Paroxysms
|
№20 / 2009
|
|
E.E. Romanova, A.A. Kirichenko
Antihypertensive Therapy In Patients With Paroxysmal Form Of Atrial Fibrillation: Is Drug Selection Important?
|
№11 / 2009
|
|
E.E. Romanova, A.A. Kirichenko
Influence Of Renin-angiotensin-aldosterone System Blockade On Atrial Fibrillation Course
|
№11 / 2009
|
|
V.A. Sulimov, D.A. Napalkov
Role Of Sotalol In The Treatment Of Heart Rhythm Disturbances: Modern Approaches
|
№6 / 2009
|
Русский
